[go: up one dir, main page]

WO1994011512A3 - Allergenic proteins and peptides from japanese cedar pollen - Google Patents

Allergenic proteins and peptides from japanese cedar pollen Download PDF

Info

Publication number
WO1994011512A3
WO1994011512A3 PCT/US1993/011000 US9311000W WO9411512A3 WO 1994011512 A3 WO1994011512 A3 WO 1994011512A3 US 9311000 W US9311000 W US 9311000W WO 9411512 A3 WO9411512 A3 WO 9411512A3
Authority
WO
WIPO (PCT)
Prior art keywords
cry
fragments
japanese cedar
peptides
cedar pollen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1993/011000
Other languages
French (fr)
Other versions
WO1994011512A2 (en
WO1994011512A9 (en
Inventor
Mei-Chang Kuo
Siu-Mei Helena Yeung
Andrew W Brauer
Joanne Pollock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immulogic Pharmaceutical Corp
Original Assignee
Immulogic Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immulogic Pharmaceutical Corp filed Critical Immulogic Pharmaceutical Corp
Priority to JP6512408A priority Critical patent/JPH08505284A/en
Priority to AU56681/94A priority patent/AU5668194A/en
Priority to EP94902242A priority patent/EP0669983A1/en
Publication of WO1994011512A2 publication Critical patent/WO1994011512A2/en
Publication of WO1994011512A3 publication Critical patent/WO1994011512A3/en
Publication of WO1994011512A9 publication Critical patent/WO1994011512A9/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention provides nucleic acid sequences coding for the Cryptomeria japonica major pollen allergen Cry j II and fragments thereof. The present invention also provides purified Cry j II and at least one fragment thereof produced in a host cell transformed with a nucleic acid sequence coding for Cry j II or at least one fragment thereof and fragments of Cry j prepared synthetically. Cry j II and fragments thereof are useful for diagnosing, treating, and preventing Japanese cedar pollinosis.
PCT/US1993/011000 1992-11-12 1993-11-12 Allergenic proteins and peptides from japanese cedar pollen Ceased WO1994011512A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP6512408A JPH08505284A (en) 1992-11-12 1993-11-12 Allergenic proteins and peptides derived from cedar pollen
AU56681/94A AU5668194A (en) 1992-11-12 1993-11-12 Allergenic proteins and peptides from japanese cedar pollen
EP94902242A EP0669983A1 (en) 1992-11-12 1993-11-12 Allergenic proteins and peptides from japanese cedar pollen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97517992A 1992-11-12 1992-11-12
US07/975,179 1992-11-12

Publications (3)

Publication Number Publication Date
WO1994011512A2 WO1994011512A2 (en) 1994-05-26
WO1994011512A3 true WO1994011512A3 (en) 1994-07-07
WO1994011512A9 WO1994011512A9 (en) 1994-07-21

Family

ID=25522765

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/011000 Ceased WO1994011512A2 (en) 1992-11-12 1993-11-12 Allergenic proteins and peptides from japanese cedar pollen

Country Status (6)

Country Link
EP (1) EP0669983A1 (en)
JP (1) JPH08505284A (en)
AU (1) AU5668194A (en)
CA (1) CA2148713A1 (en)
NZ (1) NZ258701A (en)
WO (1) WO1994011512A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104519896B (en) * 2012-06-15 2017-11-10 免疫治疗有限公司 Nucleic acids for the treatment of allergy

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4176820B2 (en) * 1993-11-05 2008-11-05 明治乳業株式会社 Cedar pollen allergen CryjII epitope
JP3649460B2 (en) * 1993-11-05 2005-05-18 明治乳業株式会社 Japanese cedar pollen allergen Cry j II epitope
DE69418433T2 (en) * 1993-11-05 1999-10-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo, Okayama Allergenic polypeptide from Japanese cedar pollen and this coding DNA
AU748104B2 (en) * 1994-09-02 2002-05-30 Merck Patent Gmbh Peptide compositions capable of down regulating an antigen specific immune response
JPH10505356A (en) * 1994-09-02 1998-05-26 イミユロジク・フアーマシユーチカル・コーポレーシヨン Compositions and methods for administration to humans, peptides capable of down-regulating an antigen-specific immune response
US6759234B1 (en) 1994-09-02 2004-07-06 Immulogic Pharmaceutical Corporation Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response
EP0700929A3 (en) * 1994-09-10 1999-09-01 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Peptide derived from cedar pollen allergens and uses thereof
EP0923940B1 (en) * 1996-03-10 2008-09-03 Meiji Dairies Corporation Peptide-based immunotherapeutic agent for allergic diseases
US6737406B1 (en) 1996-03-21 2004-05-18 Circassia, Ltd. Cryptic peptides and method for their identification
JP4176750B2 (en) * 1996-06-14 2008-11-05 明治乳業株式会社 T cell epitope peptide
DE69737659T2 (en) 1996-06-14 2007-12-27 Meiji Dairies Corp. PEPTIDES FROM T-CELL PITOPES
DE19957904A1 (en) * 1999-12-01 2001-06-07 Merck Patent Gmbh Insect venom allergens with reduced IgE reactivity and process for their preparation
AU2010312486B2 (en) 2009-10-30 2013-10-10 National Institute Of Agrobiological Sciences Protein having cedar pollen immunogenicity, polynucleotide for coding for said protein, and uses of said protein and polynucleotide

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0416816A1 (en) * 1989-09-02 1991-03-13 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Hyposensitization agent
WO1992003551A1 (en) * 1990-08-13 1992-03-05 Biomay Biotechnik Produktions- Und Handelsgesellschaft M.B.H. Birch pollen allergen p14 for diagnosis and therapy of allergic diseases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0416816A1 (en) * 1989-09-02 1991-03-13 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Hyposensitization agent
WO1992003551A1 (en) * 1990-08-13 1992-03-05 Biomay Biotechnik Produktions- Und Handelsgesellschaft M.B.H. Birch pollen allergen p14 for diagnosis and therapy of allergic diseases

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
M. SAKAGUCHI ET AL.;: "Identification of the second major allergen of Japanese cedar pollen", ALLERGY, vol. 45, 1990, pages 309 - 312 *
M. TANIAI ET AL.;: "N-terminal amino acid sequence of a major allergen of Japanese cedar pollen", FEBS LETTERS, vol. 239, 1988, pages 329 - 332 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104519896B (en) * 2012-06-15 2017-11-10 免疫治疗有限公司 Nucleic acids for the treatment of allergy

Also Published As

Publication number Publication date
NZ258701A (en) 1996-11-26
WO1994011512A2 (en) 1994-05-26
CA2148713A1 (en) 1994-05-26
EP0669983A1 (en) 1995-09-06
AU5668194A (en) 1994-06-08
JPH08505284A (en) 1996-06-11

Similar Documents

Publication Publication Date Title
CA2148253A1 (en) Allergenic proteins and peptides from johnson grass pollen
WO1994011512A3 (en) Allergenic proteins and peptides from japanese cedar pollen
WO2000058473A3 (en) Nucleic acids including open reading frames encoding polypeptides; 'orfx'
SG49097A1 (en) Nucleotide sequences coding for a protein with urease activity
AU7165287A (en) DNA encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof
EP2311952A3 (en) Antibodies to MRT-1 protein or fragments thereof
EP1862472A3 (en) Chlamydia protein, gene sequence and uses thereof
WO2000006738A3 (en) NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE)
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
WO2001070775A3 (en) Wnt-1 related polypeptides, and nucleic acids encoding the same
WO1994021675A3 (en) T cell epitopes of ryegrass pollen allergen
WO1993021321A3 (en) T CELL EPITOPES OF THE MAJOR ALLERGENS FROM $i(AMBROSIA ARTEMISIIFOLIA)
CA2173102A1 (en) Dna sequence coding for a bmp receptor
WO1992002621A3 (en) Allergens of alder pollen and applications thereof
CA2089735A1 (en) Ryegrass pollen allergen
AU1239997A (en) Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of Borna disease virus, nucleic acid fragments coding therefore and their use for diagnostic and immunization purposes
DE69032868D1 (en) ALLERGENIC PROTEINS FROM AMBROSIA AND USE THEREOF
WO1998025956A3 (en) Human GTP-binding proteins
AUPP627498A0 (en) Novel peptides - i
EP1443055A3 (en) Interleukins-21 and 22
EP0656012A4 (en) T cell epitopes of ryegrass pollen allergen.
WO1994016085A3 (en) Hybrid proteins having cross-linking and tissue-binding activities
CA2128215A1 (en) Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
DE59410221D1 (en) RECOMBINANT CHLADOSPORIUM HERBARUM ALLERGENS
WO1987007472A3 (en) A dna sequence encoding the mas oncogene, polypeptides encoded therefrom, and diagnostic and other methods based thereon

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP KR NZ

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

COP Corrected version of pamphlet

Free format text: PAGES 1/18-18/18,DRAWINGS,REPLACED BY NEW PAGES 1/22-22/22;DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 258701

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2148713

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1994902242

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1994902242

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1994902242

Country of ref document: EP